Pfizer, Inc. · NYSE:PFE
Pfizer — First Fridays Webinar Series (July 2010)
15 slides from Pfizer's conference presentation, Jul 9, 2010
Slide 1: First Fridays Webinar Series: Medical Education Group (MEG)
First Fridays Webinar Series: Medical Education Group (MEG) July 9th, 2010 Series Goals (5) 1. To provide insights into how Pfizer’s Medical Education Group (MEG) functions – an operational overview 2. To share an up-to-date status of Pfizer’s MEG timelines and grant review cycles 3. To share best p
Slide 2: Agenda and Today's Objectives
Agenda 1. Introduction 2. Topic One: Recent Communications 3. Topic Two: Scorecard Criteria 4. Q and A Today’s Objectives (3) Upon completion of today’s call, participants should be able to: 1. Describe how the processes of MEG are designed to support the Mission, Vision, and Goals of the group 2. C
Slide 3: Who is MEG? Mission, Vision, and Goals
Who is MEG? MEG Strategy MEG Operations Maureen Doyle-Scharff, MBA, FACME Ericka Eda, MBA, CPA Senior Director, Team Lead Director, Team Lead Susan Connelly, PharmD, MBA Christine Perri Education Director, Specialty Grant Manager, Specialty Robert E. Kristofco, MSW, FACME Laura Bartolomeo Education
Slide 4: Why Does MEG exist? The MEG 2-Step: Overview
Why Does MEG exist? • MEG exists to provide educational grant support to the medical community in a compliant and effective manner • Effective education accelerates the adoption curve of evidence-based clinical skills and practices • By funding good education, commercial support improves the quality
Slide 5: Q3 Timeline
MEG Web Portal: www.pfizermededgrants.com Q3 Timeline • June 1st grant request window opened ~ 6 wks • July 15th grant request window closed • July 16th GMs begin to triage and review ~ 8 days • July 26th GMs and EDs collaborative review ~ 6 wks • September 4th Decisions are communicated 5
Slide 6: Recent Communications: Call for Grant Application FAQs
Recent Communications Call for Grant Application FAQs Q1: Can any educational provider respond to these CGAs? A1: All providers that are eligible to apply for independent medical education grant requests through Pfizer are encouraged to apply for grant support. Q2: Will Pfizer continue to support gr
Slide 7: Two Recent LOA Changes; Summary of MEG Process
Two Recent LOA Changes Monitoring Activities Changes in Scope • Random samples of approved • We realize this happens – a lot medical education grants will • Dollars are approved in line be audited with the submitted proposal • Providers will be given notice • Changes to educational need, of Pfizer’s
Slide 8: Overview of MEG Scorecard
Overview of MEG Scorecard EVERY Request is Reviewed and Scored Automatic Road Blocks 8
Slide 9: Our World of Compliance
Our World of Compliance • All educational content should be balanced and representative of all treatments, where data exist faculty may also review investigational therapies – The FDA Guidance for Industry-Supported Scientific and Educational Activities – The AMA CME Guidelines • We follow the guide
Slide 10: Alignment
Alignment s 27 Clin age ical Ar 15 P e as Examples of Quality Indicators Qualifications/Experience of Provider and Educational Partner Financial Reconciliation Outcomes Data Past Performance Matters Activity Execution 10
Slide 11: Needs Assessment
Needs Assessment • The needs assessment is minimal or does not exist • The needs assessment has a literature review but does not go beyond articulating the science area of need and/or includes only broad generalized data • Goes beyond basic literature review and begins to link the science foundation
Slide 12: Educational Design
Educational Design •One-off traditional education with no evidence of innovation or incorporation of adult learning principles, no pre-activity or follow-up. Online activity with no interactivity such as written text or power point slides. •One-off activity but with some degree of interactivity. •≥
Slide 13: Outcomes Measures; Educational Innovation
Outcomes Measures • None or measurements limited to participation and/or satisfaction. • Measurements include acquisition of knowledge, skills or attitude change. • Follow up with learners will ask about self-reported change in practice or use methodology like case vignettes to assess likelihood of
Slide 14: Societal/External Impact; Summary
Societal/External Impact • Proprietary information • Publication of results • Education is lost in a sea • Education on a critical of similar educational disease area where little initiatives education is available • One-size-fits-all approach • Impact on disparities in care Summary • A second set o
Slide 15: How can we help?
Until Next Time…. 1. 2010 goal to improve dialogue with the CE community • Upcoming webinars: • August 6th – Invitations to be sent out around July 25th • 11AM EST: Sep 10 – Oct 1 – Nov 5 – Dec 3 2. If you have comments of suggestions please send an email: mededgrants@pfizer.com How can we help? 15